Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Talecris Biotherapeutics

Talecris Biotherapeutics?uq=K9LEA9hy
1942 FOUNDED
M&A STATUS
5K-10K EMPLOYEES
M&A LATEST DEAL TYPE
6 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of plasma-derived protein therapies worldwide. The company develops, produces, markets, and distributes therapies for the people suffering from chronic and acute immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. Its also offers Hyperimmunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. In addition, the company provides plasma-derived hemostasis products to treat patients who lack the necessary factors for blood clotting and suffer from conditions in which clotting occurs; and PPF-powder for the fermentation of Kogenate.

Formerly Known As
Bayer AG (Blood Plasma Business)
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 4101 Research Commons
  • 79 T.W. Alexander Drive
  • Durham, NC 27709
  • United States

+1 (919) 000-0000

Talecris Biotherapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Talecris Biotherapeutics‘s full profile, request access.

Request full access to PitchBook

Talecris Biotherapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 00 20-Nov-2006 0000000000 Other Healthcare Services 0000000 00000000
To view this company’s complete investment and acquisition history, request access »

Talecris Biotherapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Talecris Biotherapeutics‘s full profile, request access.

Request full access to PitchBook

Talecris Biotherapeutics Executive Team (9)

Name Title Board
Seat
Contact
Info
Lawrence Stern Chairman & Chief Executive Officer
John Hanson Executive Vice President & Chief Financial Officer
Bruce Nogales Senior Vice President & General Manager

6 Former Executives

You’re viewing 3 of 9 executives. Get the full list »

Talecris Biotherapeutics Board Members (2)

Name Representing Role Since Contact
Info
00000000 00000 Self Chairman & Chief Executive Officer 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »